Search results
Emcure Pharmaceuticals IPO opens today: GMP, subscription status, review, other details. Apply or...
Livemint· 1 day agoEmcure Pharmaceuticals IPO subscription opens with ₹582 crore raised from anchor investors. Price...
Staggered bets in multi-asset MFs look apt amid bullish sentiment
The Economic Times· 2 hours agoET Intelligence Group: With the benchmark Sensex touching a record 80K mark, distributors recommend...
Sebi cuts face value of debt securities to boost retail participation
Business Standard India· 14 hours agoMarkets regulator Sebi on Wednesday drastically cut the face value of debt securities to Rs 10,000...
Realty research to help homeowners
Indiatimes· 3 days agoThis partnership aims to benefit nearly 1,300 apartment and villa resident welfare associations (RWAs), representing almost 300,000 households and...
Call for value addition to enhance acceptability of millets among people
The Hindu· 7 days agoScientists have called for value addition to the millet crop to ensure increased acceptability among...
Sebi issues showcause notices to Hindenburg Research, five others
Business Standard India· 1 day agoAccording to the SCN, as disclosed on the Hindenburg Research's website, Kingdon — through a...
Emcure Pharmaceuticals IPO: 10 key risks investors should consider before subscribing to the...
Livemint· 18 hours agoEmcure Pharmaceuticals IPO sails through first day of bidding smoothly led by non institutional and...
Hindenburg Research gets show cause notice from SEBI about Adani short bet | Stock Market News
Livemint· 2 days agoHindenburg Research, the US-based short-seller, said on Monday that India’s capital market regulator...
What Hindenburg said about Kotak Bank after SEBI show cause notice over Adani Group report
The Week· 2 days agoHindenburg Research, a US short seller that had accused the Adani Group of stock market manipulation...
Adani-Hindenburg saga: Have side roles come to light?
Livemint· 1 hour agoKingdon, a US-based hedge fund, was named by Sebi’s notice as Hindenburg’s sole investor. It began...